Steven Greer - Sirius Film June 13, 2013 Steven M. Greer, MD is Founder of The Disclosure Project, The Center for the Study of Extraterrestrial Intelligence (CSETI) and The Orion Project. He is the author of four books and multiple DVDs on the UFO/ET subject. He teaches groups throughout the world how to make peaceful contact with extraterrestrial civilizations, and continues to research bringing truly alternative energy sources out to the public. Greer has led research teams throughout the world investigating the existence of ETI and on several occasions has successfully established preliminary contact and communication with extraterrestrial spacecraft at close range. We'll discuss the crowd funded documentary called Sirius, which features Steven along with numerous government and military witnesses to UFO and ET secrecy. Sirius deals not only with the subject of UFO and ET visitation disclosure but also with the advanced, clean, and alternative energy technology that's getting them here. Steven will talk about how these technologies, some of which have been suppressed for decades, can enable humanity to leave the age of the polluting petrodollar and transform society and improve mankind's chances for survival. He also tells us about his new R&D lab in the works. Later, we talk about the controversial aspects of the documentary. The hour ends on coherent thought sequencing used as a tool for primary vectoring of spacecrafts from deep space. Steven also explains how ET life forms, which have found their way to our corner of the galaxy, have evolved technologies which assist their ability to interface with consciousness.
The Met Office is to hold an emergency meeting of experts to discuss the increasingly unusual weather in the UK, it has been reported.
It follows the coldest spring in more than 50 years, as well as droughts and floods in 2012 and the freezing winter of 2010.
Climate scientists and meteorologists will travel to the forecaster's headquarters in Exeter on Tuesday for the unprecedented meeting, the Guardian said.
Attendees are expected to debate whether the changing weather pattern in the UK, and in northern Europe, is because of climate change or simply variable weather.
A Met Office spokesman told the Guardian: "We have seen a run of unusual seasons in the UK and northern Europe, such as the cold winter of 2010, last year's wet weather and the cold spring this year.
"This may be nothing more than a run of natural variability, but there may be other factors impacting our weather ... there is emerging research which suggests there is a link between declining Arctic sea ice and European climate - but exactly how this process might work and how important it may be among a host of other factors remains unclear."
Experts will identify what further research is needed and discuss whether climate models need to be revised to take into account any recent changes to weather patterns
It comes after the National Farmers Union reported that wheat harvests are likely to be around 30% lower than last year as a result of the extreme weather.
Earlier this month the Met Office said below average temperatures throughout March, April and May made it the fifth coldest spring in national records dating back to 1910 and the coldest spring since 1962.
Bioengineers at Harvard University have created the first examples of cyborg tissue: Neurons, heart cells, muscle, and blood vessels that are interwoven by nanowires and transistors.
These cyborg tissues are half living cells, half electronics. As far as the cells are concerned, they’re just normal cells that behave normally — but the electronic side actually acts as a sensor network, allowing a computer to interface directly with the cells. In the case of cyborg heart tissue, the researchers have already used the embedded nanowires to measure the contractions (heart rate) of the cells.
To create cyborg flesh, you start with a three-dimensional scaffold that encourages cells to grow around them. These scaffolds are generally made of collagen, which makes up the connective tissue in almost every animal. The Harvard engineers basically took normal collagen, and wove nanowires and transistors into the matrix to create nanoelectric scaffolds (nanoES). The neurons, heart cells, muscle, and blood vessels were then grown as normal, creating cyborg tissue with a built-in sensor network.
Cardiac cells, with a nanoelectroic electrode highlighted
So far the Havard team has mostly grown rat tissues, but they have also succeeded in growing a 1.5-centimeter (0.6in) cyborg human blood vessel. They’ve also only used the nanoelectric scaffolds to read data from the cells — but according to lead researcher Charles Lieber, the next step is to find a way of talking to the individual cells, to “wire up tissue and communicate with it in the same way a biological system does.”
A computer chip, containing a sample of nanoES tissue
Suffice it to say, if you can use a digital computer to read and write data to your body’s cells, there are some awesome applications. If you need a quick jolt of adrenaline, you would simply tap a button on your smartphone, which is directly connected to your sympathetic nervous system. You could augment your existing physiology with patches — a patch of nanoelectric heart cells, for example, that integrates with your heart and reports back if you experience any problems. When we eventually put nanobots into our bloodstream, small pulses of electricity emitted by the cells could be used as guidance to damaged areas. In the case of blood vessels and other organs, the nanoelectric sensor network could detect if there’s inflammation, blockage, or tumors.
You can’t look at internet news lately without seeing the latest and greatest in nanotechnology developments. Everything these days is being manufactured smaller, faster, more durable, and under more and more human control with the help of science. Nanotechnology is a giant rising star in business, already cresting $225 billion dollars in product sales as of 2009 with exponential growth continuing. It’s the cure-all, the golden egg, or the philosopher’s stone, if you will, of the modern world of science. As such, every other industry wants a piece of this new revenue pie and is developing nanotech faster than we can think about it.
What’s not understood, however, is the effects that nanomaterial will have on humans and the environment. More than anything else, that’s a cause for concern that everyone should pause and take note of.
Chances are you have been using products that contain nanomaterials for a couple years now, from clothing to cosmetics to even paint. Building objects from the atomic level adds a layer of customization and refinement that we’re not able to find in nature, not to mention many substances are shown to have abnormal and useful qualities when shaped in such a form, like self-cleaning t-shirts and plaque-fighting silver in toothpaste.
But nanomaterial’s strength in its size is also its weakness. They can be easily ingested or absorbed through the skin and can bleed into the environment at any point between manufacturing and use. This behavior and its effects are not entirely understood by science at this point, and the gap is only going to get wider as more and more industries delve into nanotech to enhance and build their products.
Lack of funds for research that evaluates risk is the main culprit of this, as well as the fact that companies that are tasked with researching that risk are also the companies whose livelihoods depend upon promotion of nanotechnology, creating a hand in the cookie jar scenario that we’ve all seen before.
An advisory panel of the National Academy of Sciences is calling for a four-part research push in the the areas of identifying sources of nanomaterial releases, processes that affect exposure and hazards, nanomaterial interactions at subcellular to ecosystem-wide levels, and ways to accelerate research progress.
To ask for such a wide array of topics to be diligently looked into should be some cause for alarm to any consumer, because the assumption then is that there is no hard data on these topics at all. According to Nano.gov, over 800 everyday commercial products already rely on nanomaterials, from baseball bats to anti-wrinkle clothing to sunscreen and — get this — nanocomposites in food containers.
It’s probably safe to say that we’re ingesting these products already, and science has no clear indication if that’s a bad thing or not.
It gets worse, as well. Future applications of nanomaterials include purifying drinking water and the very air we breathe, among other things. Is this a situation where the cure is worse than the malady? How do we know?
Engineers at Stanford have finally managed to create a wirelessly powered and controlled device that’s small enough to travel through your bloodstream. Future versions will carry sensors and drug delivery systems, for the ultimate in pin-point accurate medicine.
The breakthrough, made by Ada Poon, is depressingly simple. Basically, for some 50 years, it has always been believed that human flesh, muscle, and bone absorb high-frequency radio waves. Low-frequency waves penetrate well, but to power a device using low-frequency waves (using induction) you need a very long antenna — something on the order of a few centimeters, which is obviously too large. Poon, who is obviously an outside-the-box thinker, decided to re-do the math — and what do you know: high-frequency radiation around 1GHz actually penetrates the human body very well. As a result, Poon’s wireless device can use an antenna that’s only two millimeters square — small enough to visit almost any portion of our vasculature.
The end result is a minute device not unlike the vessel in Innerspace that’s capable of traveling 0.5cm per second. It is controlled using a wireless transmitter, which would presumably be held by a surgeon or a nurse. In the future, you might be able to use some kind of walk-in machine where a computer/robot controls the device. The next step for Ada Poon and her team at Stanford will be to attach sensors or a drug delivery system. Before we know it, Poon’s device could be whizzing around your blood vessels looking for build-ups of arterial plaque, signs of blood clots, and targeting cancerous tumors with drugs.
With the continued miniaturization of computer chips, there has been a lot of progress in this area recently. Just last week MIT unveiled a wirelessly controlled chip that sits under your skin and delivers drugs. The idea is that these chips might one day contain a whole “pharmacy” of drugs, and that doctors could control them from a distance using telemedicine. Last year we wrote about self-assembling nanobots that could one day ferry drugs around your body.